Strength of the Pack: The Personalities, Politics and Espionage Intrigues. Douglas Valentine, 2010, ISBN 978-1-936296-91-0 (Google Books [abgerufen am 13. Mai 2018]).
Richard R. Abood: Pharmacy Practice and the Law. Jones & Bartlett, 2012, ISBN 978-1-4496-8691-8, The Closed System of Controlled Substance Distribution, S.184 (Google Books [abgerufen am 30. Dezember 2012]).
David T. Courtwright: The Controlled Substances Act: how a „big tent“ reform became a punitive drug law. In: Drug and Alcohol Dependence. Band76, Nr.1, 5. Oktober 2004, S.9–15, doi:10.1016/j.drugalcdep.2004.04.012, PMID 15380284.
Paul Gee, Mark Gilbert, Sandra Richardson, Grant Moore, Sharon Paterson, Patrick Graham: Toxicity from the Recreational Use of 1-benzylpiperazine. In: Clinical Toxicology. Band46, Nr.9, 2008, S.802–07, doi:10.1080/15563650802307602, PMID 18821145.
K. Brennan, A. Johnstone, P. Fitzmaurice, R. Lea, S. Schenk: Chronic Benzylpiperazine (BZP) Exposure Produces Behavioral Sensitization and Cross-sensitization to Methamphetamine (MA). In: Drug and Alcohol Dependence. Band88, Nr.2–3, 2007, S.204–13, doi:10.1016/j.drugalcdep.2006.10.016, PMID 17125936.
G. Tunnicliff: Sites of action of gamma hydroxybutyrate (GHB) – A neuroactive drug with abuse potential. In: Clinical Toxicology. Band35, Nr.6, 1997, S.581–590, doi:10.3109/15563659709001236.
J.H. Halpern: Hallucinogens and dissociative agents naturally growing in the United States. In: Pharmacology & Therapeutics. Band102, Nr.2, 2004, S.131–138, doi:10.1016/j.pharmthera.2004.03.003, PMID 15163594.
David J. Nutt, Leslie A. King, Lawrence D. Phillips Independent Scientific Committee on Drugs: Drug harms in the UK: A multicriteria decision analysis. In: The Lancet. Band376, Nr.9752, 6. November 2010, S.1558–1565, doi:10.1016/S0140-6736(10)61462-6, PMID 21036393.
DrugFacts: Is Marijuana Medicine? In: National Institute on Drug Abuse. National Institutes of Health; U.S. Department of Health and Human Services, Juli 2015; abgerufen im 1. Januar 1 (englisch).
Public Policy Options (= Canadian Senate Special Committee on Illegal Drugs. Band3). Schaffer Library of Drug Policy, The 1912 Hague International Opium Convention (Online).
Donnie Marshall: Notice of denial of petition to reschedule marijuana. In: Federal Register. Band66, Nr.75. Drug Enforcement Administration, 20. März 2001, S.20038–20076 (Online [abgerufen am 13. Juni 2013]).
91. Kongress der Vereinigten Staaten: An Act to amend the Public Health Service Act and other laws to provide increased research, into, and prevention of, drug abuse and drug dependence; to provide for treatment and rehabilitation of drug abusers and drug dependent persons; and to strengthen existing law enforcement authority in the field of drug abuse. U.S. Government Publishing Office, 1970, Part F – Advisory Commission: Establishment of Commission on Marihuana and Drug Abuse, S.1280–1281.Pub.L.91-513, 84 Stat. 1236, erlassen am 27. Oktober 1970
David T. Courtwright: The Controlled Substances Act: how a „big tent“ reform became a punitive drug law. In: Drug and Alcohol Dependence. Band76, Nr.1, 5. Oktober 2004, S.9–15, doi:10.1016/j.drugalcdep.2004.04.012, PMID 15380284.
Paul Gee, Mark Gilbert, Sandra Richardson, Grant Moore, Sharon Paterson, Patrick Graham: Toxicity from the Recreational Use of 1-benzylpiperazine. In: Clinical Toxicology. Band46, Nr.9, 2008, S.802–07, doi:10.1080/15563650802307602, PMID 18821145.
K. Brennan, A. Johnstone, P. Fitzmaurice, R. Lea, S. Schenk: Chronic Benzylpiperazine (BZP) Exposure Produces Behavioral Sensitization and Cross-sensitization to Methamphetamine (MA). In: Drug and Alcohol Dependence. Band88, Nr.2–3, 2007, S.204–13, doi:10.1016/j.drugalcdep.2006.10.016, PMID 17125936.
J.H. Halpern: Hallucinogens and dissociative agents naturally growing in the United States. In: Pharmacology & Therapeutics. Band102, Nr.2, 2004, S.131–138, doi:10.1016/j.pharmthera.2004.03.003, PMID 15163594.
David J. Nutt, Leslie A. King, Lawrence D. Phillips Independent Scientific Committee on Drugs: Drug harms in the UK: A multicriteria decision analysis. In: The Lancet. Band376, Nr.9752, 6. November 2010, S.1558–1565, doi:10.1016/S0140-6736(10)61462-6, PMID 21036393.
Federal Pseudoephedrine Law. In: doh.state.fl.us. Florida Department of Health, Division of Medical Quality Assurance, 5. Oktober 2006, archiviert vom Original am 30. Juli 2012; abgerufen am 20. Oktober 2012 (englisch).
Drug Scheduling. Drug Enforcement Administration, United States Department of Justice, archiviert vom Original am 9. August 2017; abgerufen im 1. Januar 1 (englisch).
Federal Pseudoephedrine Law. In: doh.state.fl.us. Florida Department of Health, Division of Medical Quality Assurance, 5. Oktober 2006, archiviert vom Original am 30. Juli 2012; abgerufen am 20. Oktober 2012 (englisch).
Drug Scheduling. Drug Enforcement Administration, United States Department of Justice, archiviert vom Original am 9. August 2017; abgerufen im 1. Januar 1 (englisch).